What’s wrong with the Supreme Court’s Pregabalin decision?

Everything to do with second medical use patents. 

Not because of any fault in the legal reasoning: because the decision came to be made by a Court at all. 

If you haven’t yet had a chance to read the Pregabalin Judgment then you can save yourself some time by reading this excellent summary by Darren Smyth of EIP.

The offending molecule

This article isn’t going to re-tread any ground. It’s about whether the law relating to second medical use patents is fit for purpose, and whether a Court should really be making these assessments, Supreme or not.

The reason you should care about patenting new uses for existing drugs, even if you’re not a patent lawyer, is because it is the future of healthcare.… Read more...